Volumetric Absorptive Microsampling (VAMS®) is the technology behind our patient-friendly Mitra® devices, which are designed for remote specimen collection. VAMS retains the benefits of dried blood spot collection (DBS) cards while solving for their limitations. Overcome the hematocrit issue with Mitra and VAMS for easy and precise specimen collection, with reliable results.
Download these case studies from Exagen Diagnostics, GlaxoSmithKline, and others for details on how to achieve the following benefits vs DBS cards:
When DBS cards debuted more than 50 years ago, they had significant advantages over traditional wet sampling, including simplicity, low cost, and ease of transportation.
Yet, adoption was hindered by regulatory concerns over the "Hematocrit (HCT) Effect" and automation limitations. In addition, incorrect spotting technique can lead to high sample rejection rates.
The FDA Class 1 Mitra® Microsampler is a remote specimen collection device that retains the advantages of DBS cards while overcoming their limitations.